Natural Product: NPC493554

Natural Product IDNPC493554
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
5-hydroxy-3-(4-hydroxyphenyl)-8-methoxy-7-[(2~{S},3~{R},4~{S},5~{S},6~{S})-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one
IUPAC Name 5-hydroxy-3-(4-hydroxyphenyl)-8-methoxy-7-[(2~{S},3~{R},4~{S},5~{S},6~{S})-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey YJBZWKGFYVMPDY-JEOJHICDSA-N
Standard InCHI InChI=1S/C22H22O11/c1-30-20-13(32-22-19(29)18(28)17(27)14(7-23)33-22)6-12(25)15-16(26)11(8-31-21(15)20)9-2-4-10(24)5-3-9/h2-6,8,14,17-19,22-25,27-29H,7H2,1H3/t14-,17+,18-,19+,22+/m0/s1
SMILES COC1=C(O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C(O)C2=C1OC=C(C1=CC=C(O)C=C1)C2=O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   462.12 Volume:   430.443
?
Van der Waals volume.
Dense:   1.074 LogP:   0.543
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.252
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.045
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   5.0 Rigid Bonds:   24.0
TPSA:   179.28
?
Topological Polar Surface Area.
H-Bond Acceptor:   11.0
H-Bond Donor:   6.0 Rings:   4.0
Heavy Atoms:   11.0

MedChem Properties

QED Drug-Likeness Score:   0.302 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.977 Fsp3:   0.318
MCE-18:   86.966
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.517 Fluc inhibitor:   0.273
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.881
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.807
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.096 Promiscuous compounds:   0.534

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.401 MDCK Permeability:   -5.28
Pgp-inhibitor:   0.0 Pgp-substrate:   0.343
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.11
20% Bioavailability (F20%):   0.299 30% Bioavailability (F30%):   0.698
50% Bioavailability (F50%):   0.984

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.003 MRP1:   0.338
Plasma Protein Binding (PPB):   85.089% Volume Distribution (VD):   -0.129
Fu: 15.593%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.685
OATP1B3 inhibitor:   0.749 BCRP inhibitor:   0.248
BSEP inhibitor:   0.057

ADMET: Metabolism

CYP1A2-inhibitor:   0.169 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.023 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.028
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.182
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  2.881 Half-life (T1/2):  3.067

ADMET: Toxicity

hERG Blockers:  0.033 hERG Blockers (10um):  0.308
Human Hepatotoxicity (H-HT):  0.603 Drug-induced Liver Injury (DILI):  0.845
AMES Toxicity:  0.725 Rat Oral Acute Toxicity:  0.1
Maximum Recommended Daily Dose:  0.071 Skin Sensitization:  0.936
Carcinogencity:  0.214 Eye Corrosion:  0.0
Eye Irritation:  0.341 Respiratory Toxicity:  0.034
Drug-induced Neurotoxicity:  0.023 Ototoxicity:  0.878
Hematotoxicity:  0.157 Drug-induced Nephrotoxicity:  0.559
Genotoxicity:  0.784 RPMI-8226 Immunitoxicity:  0.101
A549 Cytotoxicity:  0.204 Hek293 Cytotoxicity:  0.306
BCF:   0.378
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   2.923
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.312
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.586
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO20912 Wisteria brachybotrys Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[2853205]
NPO20912 Wisteria brachybotrys Species Fabaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO20912 Wisteria brachybotrys Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC493554 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7308 Intermediate Similarity NPC205076
0.7273 Intermediate Similarity NPC197896
0.7273 Intermediate Similarity NPC313163
0.7051 Intermediate Similarity NPC105511
0.6543 Remote Similarity NPC73511
0.6463 Remote Similarity NPC100720
0.6386 Remote Similarity NPC481043
0.622 Remote Similarity NPC161749
0.622 Remote Similarity NPC156457
0.618 Remote Similarity NPC479405
0.6163 Remote Similarity NPC48773
0.6111 Remote Similarity NPC479404
0.6098 Remote Similarity NPC348541
0.6049 Remote Similarity NPC93099
0.6024 Remote Similarity NPC603782
0.6 Remote Similarity NPC80140
0.5904 Remote Similarity NPC259070
0.5862 Remote Similarity NPC307518
0.5833 Remote Similarity NPC258035
0.5814 Remote Similarity NPC224462
0.5783 Remote Similarity NPC135345
0.5698 Remote Similarity NPC138540
0.5647 Remote Similarity NPC234739
0.5455 Remote Similarity NPC479401
0.5444 Remote Similarity NPC479407
0.5412 Remote Similarity NPC45165
0.5349 Remote Similarity NPC210042
0.5349 Remote Similarity NPC44558
0.5333 Remote Similarity NPC479406
0.5319 Remote Similarity NPC303913
0.5287 Remote Similarity NPC323593
0.5287 Remote Similarity NPC203500
0.5233 Remote Similarity NPC177308
0.5233 Remote Similarity NPC160515
0.5227 Remote Similarity NPC105025
0.5222 Remote Similarity NPC229729
0.52 Remote Similarity NPC131266
0.5172 Remote Similarity NPC39360
0.5172 Remote Similarity NPC29763
0.5172 Remote Similarity NPC211014
0.5172 Remote Similarity NPC210003
0.5155 Remote Similarity NPC479403
0.5114 Remote Similarity NPC93337
0.5114 Remote Similarity NPC297987
0.5111 Remote Similarity NPC168584
0.5111 Remote Similarity NPC479402
0.5106 Remote Similarity NPC480466
0.506 Remote Similarity NPC78697
0.5056 Remote Similarity NPC24043
0.5056 Remote Similarity NPC488080
0.5056 Remote Similarity NPC169977

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC493554 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.622 Remote Similarity NPD4381 Clinical (unspecified phase)
0.5412 Remote Similarity NPD3818 Discontinued

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data